Last ¥4,547 JPY
Change Today +1.00 / 0.02%
Volume 1.2M
4502 On Other Exchanges
Symbol
Exchange
Tokyo
OTC US
OTC US
Frankfurt
As of 2:00 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

Transactions by TAKEDA PHARMACEUTICAL CO LTD (4502) in the last 6 months

Announced 03/31/14
Takeda Analytical Research Laboratories Ltd.
Merger/Acquisition

Sumika Chemical Analysis Service, Ltd. acquired Takeda Analytical Research Laboratories Ltd. from Takeda Pharmaceutical Company Limited (TSE:4502) on March 31, 2014.


4502's price was unchanged after the transaction was announced on 03/31/14.
Investor / Buyer
Sumika Chemical Analysis Service, Ltd.
Creditor / Lender
Takeda Pharmaceutical Company Limited
 
Announced 03/6/14
1.29B for Ohki Co., Ltd.
Private Placement

Ohki Co., Ltd. (JASDAQ:8120) announced a private placement of 1,500,000 common shares and 1,130,000 treasury shares at ¥490 per share for gross proceeds of ¥1,288,700,000 on March 6, 2014. The shares will be issued by third party allotment. The transaction will include participation from a total of 26 investors including, Kokubu & Co., Ltd., which will invest for 1,000,000 shares, Takeda Pharmaceutical Co., Ltd., which will invest for 400,000 shares, and Asahi Food & ...
Read More


4502's price was unchanged after the transaction was announced on 03/6/14.
Investor / Buyer
Asahi Food & Healthcare Co., Ltd.
Earth Chemical Co., Ltd.
FINE Co., LTD.
Hakujuji Co., Ltd.
Hisamitsu Pharmaceutical Co. Inc.
Japan Medic Co., Ltd.
Kawamoto Corporation
Kinyo Pharmaceutical Co.,Ltd
Kobayashi Pharmaceutical Co. Ltd.
Kokubu & Co., Ltd.
Kyushin Pharmaceutical Co., Ltd.
Megmilk Snow Brand Co., Ltd.
Meiji Co., Ltd.
Meiji Yakuhin Co.Ltd.
Metabolic Co., Ltd.
Morinaga Milk Industry Co., Ltd.
Mune Pharmaceutical Co., Ltd.
Oishi Koseido Co., Ltd.
Ophtecs Corporation
POKKA SAPPORO Food & Beverage Ltd.
Rachel Seiyaku Co., Ltd.
Ryukakusan Co., Ltd.
Seed Co.,Ltd.
Takeda Pharmaceutical Company Limited
YAKUO Pharmaceutical co.,ltd.
Yuskin Pharmaceutical Co.,Ltd.
 
Announced 01/9/14
Two Experimental Blood Cancer Drugs
Merger/Acquisition

Sunesis Pharmaceuticals, Inc. (NasdaqCM:SNSS) acquired two experimental blood cancer drugs licenses from Biogen Idec Inc. (NasdaqGS:BIIB) and the cancer unit of Takeda Pharmaceutical Company Limited (TSE:4502) on January 9, 2014.


4502's price was unchanged after the transaction was announced on 01/9/14.
Investor / Buyer
Sunesis Pharmaceuticals, Inc.
Creditor / Lender
Biogen Idec Inc.
Takeda Pharmaceutical Company Limited
 
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4502:JP ¥4,547.00 JPY +1.00

4502 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $197.39 USD -1.99
Astellas Pharma Inc ¥1,139 JPY -1.00
Baxter International Inc $72.81 USD -0.64
Becton Dickinson and Co $113.16 USD +0.23
Merck KGaA €115.25 EUR +0.45
View Industry Companies
 

Industry Analysis

4502

Industry Average

Valuation 4502 Industry Range
Price/Earnings 35.8x
Price/Sales 2.2x
Price/Book 1.5x
Price/Cash Flow 35.7x
TEV/Sales 1.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.